Global Dactinomycin Market Growth (Status and Outlook) 2025-2031

September 2025 | 107 pages | ID: GADE2706A2A2EN
LP Information

Abstracts

According to this study, the global Dactinomycin market size will reach US$ million by 2031.

Dactinomycin is a mixture of Streptomyces chrysomallus, mainly composed of C1, C2, C3 and D.Red or orange-yellow crystalline powder of madder.Soluble in ethanol, acetone and benzene.Its effect is similar to that of actinomycin, and it has a wide antitumor spectrum.In addition, also has the strong resistance bacteria, fungi and viruses.It is mainly used for Hodgkin's disease, nephroblastoma and leukemia in children.The toxic and side effects are similar to those of actinomycin, mainly myelosuppression and gastrointestinal reactions.Advanced malignant tumors, low red and white blood cells and pregnant women are contraindicated.

United States market for Dactinomycin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Dactinomycin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Dactinomycin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Dactinomycin players cover AstraZeneca, GSK, Recordati Rare Diseases, Lundbeck, Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Dactinomycin Industry Forecast” looks at past sales and reviews total world Dactinomycin sales in 2024, providing a comprehensive analysis by region and market sector of projected Dactinomycin sales for 2025 through 2031. With Dactinomycin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dactinomycin industry.

This Insight Report provides a comprehensive analysis of the global Dactinomycin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Dactinomycin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dactinomycin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dactinomycin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dactinomycin.

This report presents a comprehensive overview, market shares, and growth opportunities of Dactinomycin market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Injection
• Implants

Segmentation by Application:

• Alkylating Agent
• Hormone
• Plant Medicine

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AstraZeneca
• GSK
• Recordati Rare Diseases
• Lundbeck
• Merck
• Prasco Laboratories
• X-GEN Pharmaceuticals
• Mylan Institutional
• Bedford Pharmaceuticals
• HISUN
• Hainan Jinrui Pharmaceutical
• Qilu Pharmaceutical
• Shanghai Zhongke Pharmaceutical
• Shanghai Xinya Pharmaceutical
• Nantong Xinhe Biotechnology

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Dactinomycin Market Size (2020-2031)
  2.1.2 Dactinomycin Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Dactinomycin by Country/Region (2020, 2024 & 2031)
2.2 Dactinomycin Segment by Type
  2.2.1 Injection
  2.2.2 Implants
2.3 Dactinomycin Market Size by Type
  2.3.1 Dactinomycin Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Dactinomycin Market Size Market Share by Type (2020-2025)
2.4 Dactinomycin Segment by Application
  2.4.1 Alkylating Agent
  2.4.2 Hormone
  2.4.3 Plant Medicine
2.5 Dactinomycin Market Size by Application
  2.5.1 Dactinomycin Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Dactinomycin Market Size Market Share by Application (2020-2025)

3 DACTINOMYCIN MARKET SIZE BY PLAYER

3.1 Dactinomycin Market Size Market Share by Player
  3.1.1 Global Dactinomycin Revenue by Player (2020-2025)
  3.1.2 Global Dactinomycin Revenue Market Share by Player (2020-2025)
3.2 Global Dactinomycin Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 DACTINOMYCIN BY REGION

4.1 Dactinomycin Market Size by Region (2020-2025)
4.2 Global Dactinomycin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Dactinomycin Market Size Growth (2020-2025)
4.4 APAC Dactinomycin Market Size Growth (2020-2025)
4.5 Europe Dactinomycin Market Size Growth (2020-2025)
4.6 Middle East & Africa Dactinomycin Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Dactinomycin Market Size by Country (2020-2025)
5.2 Americas Dactinomycin Market Size by Type (2020-2025)
5.3 Americas Dactinomycin Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Dactinomycin Market Size by Region (2020-2025)
6.2 APAC Dactinomycin Market Size by Type (2020-2025)
6.3 APAC Dactinomycin Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Dactinomycin Market Size by Country (2020-2025)
7.2 Europe Dactinomycin Market Size by Type (2020-2025)
7.3 Europe Dactinomycin Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Dactinomycin by Region (2020-2025)
8.2 Middle East & Africa Dactinomycin Market Size by Type (2020-2025)
8.3 Middle East & Africa Dactinomycin Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL DACTINOMYCIN MARKET FORECAST

10.1 Global Dactinomycin Forecast by Region (2026-2031)
  10.1.1 Global Dactinomycin Forecast by Region (2026-2031)
  10.1.2 Americas Dactinomycin Forecast
  10.1.3 APAC Dactinomycin Forecast
  10.1.4 Europe Dactinomycin Forecast
  10.1.5 Middle East & Africa Dactinomycin Forecast
10.2 Americas Dactinomycin Forecast by Country (2026-2031)
  10.2.1 United States Market Dactinomycin Forecast
  10.2.2 Canada Market Dactinomycin Forecast
  10.2.3 Mexico Market Dactinomycin Forecast
  10.2.4 Brazil Market Dactinomycin Forecast
10.3 APAC Dactinomycin Forecast by Region (2026-2031)
  10.3.1 China Dactinomycin Market Forecast
  10.3.2 Japan Market Dactinomycin Forecast
  10.3.3 Korea Market Dactinomycin Forecast
  10.3.4 Southeast Asia Market Dactinomycin Forecast
  10.3.5 India Market Dactinomycin Forecast
  10.3.6 Australia Market Dactinomycin Forecast
10.4 Europe Dactinomycin Forecast by Country (2026-2031)
  10.4.1 Germany Market Dactinomycin Forecast
  10.4.2 France Market Dactinomycin Forecast
  10.4.3 UK Market Dactinomycin Forecast
  10.4.4 Italy Market Dactinomycin Forecast
  10.4.5 Russia Market Dactinomycin Forecast
10.5 Middle East & Africa Dactinomycin Forecast by Region (2026-2031)
  10.5.1 Egypt Market Dactinomycin Forecast
  10.5.2 South Africa Market Dactinomycin Forecast
  10.5.3 Israel Market Dactinomycin Forecast
  10.5.4 Turkey Market Dactinomycin Forecast
10.6 Global Dactinomycin Forecast by Type (2026-2031)
10.7 Global Dactinomycin Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Dactinomycin Forecast

11 KEY PLAYERS ANALYSIS

11.1 AstraZeneca
  11.1.1 AstraZeneca Company Information
  11.1.2 AstraZeneca Dactinomycin Product Offered
  11.1.3 AstraZeneca Dactinomycin Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 AstraZeneca Main Business Overview
  11.1.5 AstraZeneca Latest Developments
11.2 GSK
  11.2.1 GSK Company Information
  11.2.2 GSK Dactinomycin Product Offered
  11.2.3 GSK Dactinomycin Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 GSK Main Business Overview
  11.2.5 GSK Latest Developments
11.3 Recordati Rare Diseases
  11.3.1 Recordati Rare Diseases Company Information
  11.3.2 Recordati Rare Diseases Dactinomycin Product Offered
  11.3.3 Recordati Rare Diseases Dactinomycin Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Recordati Rare Diseases Main Business Overview
  11.3.5 Recordati Rare Diseases Latest Developments
11.4 Lundbeck
  11.4.1 Lundbeck Company Information
  11.4.2 Lundbeck Dactinomycin Product Offered
  11.4.3 Lundbeck Dactinomycin Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Lundbeck Main Business Overview
  11.4.5 Lundbeck Latest Developments
11.5 Merck
  11.5.1 Merck Company Information
  11.5.2 Merck Dactinomycin Product Offered
  11.5.3 Merck Dactinomycin Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Merck Main Business Overview
  11.5.5 Merck Latest Developments
11.6 Prasco Laboratories
  11.6.1 Prasco Laboratories Company Information
  11.6.2 Prasco Laboratories Dactinomycin Product Offered
  11.6.3 Prasco Laboratories Dactinomycin Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Prasco Laboratories Main Business Overview
  11.6.5 Prasco Laboratories Latest Developments
11.7 X-GEN Pharmaceuticals
  11.7.1 X-GEN Pharmaceuticals Company Information
  11.7.2 X-GEN Pharmaceuticals Dactinomycin Product Offered
  11.7.3 X-GEN Pharmaceuticals Dactinomycin Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 X-GEN Pharmaceuticals Main Business Overview
  11.7.5 X-GEN Pharmaceuticals Latest Developments
11.8 Mylan Institutional
  11.8.1 Mylan Institutional Company Information
  11.8.2 Mylan Institutional Dactinomycin Product Offered
  11.8.3 Mylan Institutional Dactinomycin Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Mylan Institutional Main Business Overview
  11.8.5 Mylan Institutional Latest Developments
11.9 Bedford Pharmaceuticals
  11.9.1 Bedford Pharmaceuticals Company Information
  11.9.2 Bedford Pharmaceuticals Dactinomycin Product Offered
  11.9.3 Bedford Pharmaceuticals Dactinomycin Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Bedford Pharmaceuticals Main Business Overview
  11.9.5 Bedford Pharmaceuticals Latest Developments
11.10 HISUN
  11.10.1 HISUN Company Information
  11.10.2 HISUN Dactinomycin Product Offered
  11.10.3 HISUN Dactinomycin Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 HISUN Main Business Overview
  11.10.5 HISUN Latest Developments
11.11 Hainan Jinrui Pharmaceutical
  11.11.1 Hainan Jinrui Pharmaceutical Company Information
  11.11.2 Hainan Jinrui Pharmaceutical Dactinomycin Product Offered
  11.11.3 Hainan Jinrui Pharmaceutical Dactinomycin Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Hainan Jinrui Pharmaceutical Main Business Overview
  11.11.5 Hainan Jinrui Pharmaceutical Latest Developments
11.12 Qilu Pharmaceutical
  11.12.1 Qilu Pharmaceutical Company Information
  11.12.2 Qilu Pharmaceutical Dactinomycin Product Offered
  11.12.3 Qilu Pharmaceutical Dactinomycin Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Qilu Pharmaceutical Main Business Overview
  11.12.5 Qilu Pharmaceutical Latest Developments
11.13 Shanghai Zhongke Pharmaceutical
  11.13.1 Shanghai Zhongke Pharmaceutical Company Information
  11.13.2 Shanghai Zhongke Pharmaceutical Dactinomycin Product Offered
  11.13.3 Shanghai Zhongke Pharmaceutical Dactinomycin Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Shanghai Zhongke Pharmaceutical Main Business Overview
  11.13.5 Shanghai Zhongke Pharmaceutical Latest Developments
11.14 Shanghai Xinya Pharmaceutical
  11.14.1 Shanghai Xinya Pharmaceutical Company Information
  11.14.2 Shanghai Xinya Pharmaceutical Dactinomycin Product Offered
  11.14.3 Shanghai Xinya Pharmaceutical Dactinomycin Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Shanghai Xinya Pharmaceutical Main Business Overview
  11.14.5 Shanghai Xinya Pharmaceutical Latest Developments
11.15 Nantong Xinhe Biotechnology
  11.15.1 Nantong Xinhe Biotechnology Company Information
  11.15.2 Nantong Xinhe Biotechnology Dactinomycin Product Offered
  11.15.3 Nantong Xinhe Biotechnology Dactinomycin Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 Nantong Xinhe Biotechnology Main Business Overview
  11.15.5 Nantong Xinhe Biotechnology Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Dactinomycin Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Dactinomycin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Implants
Table 5. Dactinomycin Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Dactinomycin Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Dactinomycin Market Size Market Share by Type (2020-2025)
Table 8. Dactinomycin Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Dactinomycin Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Dactinomycin Market Size Market Share by Application (2020-2025)
Table 11. Global Dactinomycin Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Dactinomycin Revenue Market Share by Player (2020-2025)
Table 13. Dactinomycin Key Players Head office and Products Offered
Table 14. Dactinomycin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Dactinomycin Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Dactinomycin Market Size Market Share by Region (2020-2025)
Table 19. Global Dactinomycin Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Dactinomycin Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Dactinomycin Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Dactinomycin Market Size Market Share by Country (2020-2025)
Table 23. Americas Dactinomycin Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Dactinomycin Market Size Market Share by Type (2020-2025)
Table 25. Americas Dactinomycin Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Dactinomycin Market Size Market Share by Application (2020-2025)
Table 27. APAC Dactinomycin Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Dactinomycin Market Size Market Share by Region (2020-2025)
Table 29. APAC Dactinomycin Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Dactinomycin Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Dactinomycin Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Dactinomycin Market Size Market Share by Country (2020-2025)
Table 33. Europe Dactinomycin Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Dactinomycin Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Dactinomycin Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Dactinomycin Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Dactinomycin Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Dactinomycin
Table 39. Key Market Challenges & Risks of Dactinomycin
Table 40. Key Industry Trends of Dactinomycin
Table 41. Global Dactinomycin Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Dactinomycin Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Dactinomycin Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Dactinomycin Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. AstraZeneca Details, Company Type, Dactinomycin Area Served and Its Competitors
Table 46. AstraZeneca Dactinomycin Product Offered
Table 47. AstraZeneca Dactinomycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. AstraZeneca Main Business
Table 49. AstraZeneca Latest Developments
Table 50. GSK Details, Company Type, Dactinomycin Area Served and Its Competitors
Table 51. GSK Dactinomycin Product Offered
Table 52. GSK Dactinomycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. GSK Main Business
Table 54. GSK Latest Developments
Table 55. Recordati Rare Diseases Details, Company Type, Dactinomycin Area Served and Its Competitors
Table 56. Recordati Rare Diseases Dactinomycin Product Offered
Table 57. Recordati Rare Diseases Dactinomycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Recordati Rare Diseases Main Business
Table 59. Recordati Rare Diseases Latest Developments
Table 60. Lundbeck Details, Company Type, Dactinomycin Area Served and Its Competitors
Table 61. Lundbeck Dactinomycin Product Offered
Table 62. Lundbeck Dactinomycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Lundbeck Main Business
Table 64. Lundbeck Latest Developments
Table 65. Merck Details, Company Type, Dactinomycin Area Served and Its Competitors
Table 66. Merck Dactinomycin Product Offered
Table 67. Merck Dactinomycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Merck Main Business
Table 69. Merck Latest Developments
Table 70. Prasco Laboratories Details, Company Type, Dactinomycin Area Served and Its Competitors
Table 71. Prasco Laboratories Dactinomycin Product Offered
Table 72. Prasco Laboratories Dactinomycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Prasco Laboratories Main Business
Table 74. Prasco Laboratories Latest Developments
Table 75. X-GEN Pharmaceuticals Details, Company Type, Dactinomycin Area Served and Its Competitors
Table 76. X-GEN Pharmaceuticals Dactinomycin Product Offered
Table 77. X-GEN Pharmaceuticals Dactinomycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. X-GEN Pharmaceuticals Main Business
Table 79. X-GEN Pharmaceuticals Latest Developments
Table 80. Mylan Institutional Details, Company Type, Dactinomycin Area Served and Its Competitors
Table 81. Mylan Institutional Dactinomycin Product Offered
Table 82. Mylan Institutional Dactinomycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Mylan Institutional Main Business
Table 84. Mylan Institutional Latest Developments
Table 85. Bedford Pharmaceuticals Details, Company Type, Dactinomycin Area Served and Its Competitors
Table 86. Bedford Pharmaceuticals Dactinomycin Product Offered
Table 87. Bedford Pharmaceuticals Dactinomycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Bedford Pharmaceuticals Main Business
Table 89. Bedford Pharmaceuticals Latest Developments
Table 90. HISUN Details, Company Type, Dactinomycin Area Served and Its Competitors
Table 91. HISUN Dactinomycin Product Offered
Table 92. HISUN Dactinomycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. HISUN Main Business
Table 94. HISUN Latest Developments
Table 95. Hainan Jinrui Pharmaceutical Details, Company Type, Dactinomycin Area Served and Its Competitors
Table 96. Hainan Jinrui Pharmaceutical Dactinomycin Product Offered
Table 97. Hainan Jinrui Pharmaceutical Dactinomycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Hainan Jinrui Pharmaceutical Main Business
Table 99. Hainan Jinrui Pharmaceutical Latest Developments
Table 100. Qilu Pharmaceutical Details, Company Type, Dactinomycin Area Served and Its Competitors
Table 101. Qilu Pharmaceutical Dactinomycin Product Offered
Table 102. Qilu Pharmaceutical Dactinomycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Qilu Pharmaceutical Main Business
Table 104. Qilu Pharmaceutical Latest Developments
Table 105. Shanghai Zhongke Pharmaceutical Details, Company Type, Dactinomycin Area Served and Its Competitors
Table 106. Shanghai Zhongke Pharmaceutical Dactinomycin Product Offered
Table 107. Shanghai Zhongke Pharmaceutical Dactinomycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Shanghai Zhongke Pharmaceutical Main Business
Table 109. Shanghai Zhongke Pharmaceutical Latest Developments
Table 110. Shanghai Xinya Pharmaceutical Details, Company Type, Dactinomycin Area Served and Its Competitors
Table 111. Shanghai Xinya Pharmaceutical Dactinomycin Product Offered
Table 112. Shanghai Xinya Pharmaceutical Dactinomycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Shanghai Xinya Pharmaceutical Main Business
Table 114. Shanghai Xinya Pharmaceutical Latest Developments
Table 115. Nantong Xinhe Biotechnology Details, Company Type, Dactinomycin Area Served and Its Competitors
Table 116. Nantong Xinhe Biotechnology Dactinomycin Product Offered
Table 117. Nantong Xinhe Biotechnology Dactinomycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Nantong Xinhe Biotechnology Main Business
Table 119. Nantong Xinhe Biotechnology Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Dactinomycin Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Dactinomycin Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Dactinomycin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Dactinomycin Sales Market Share by Country/Region (2024)
Figure 8. Dactinomycin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Dactinomycin Market Size Market Share by Type in 2024
Figure 10. Dactinomycin in Alkylating Agent
Figure 11. Global Dactinomycin Market: Alkylating Agent (2020-2025) & ($ millions)
Figure 12. Dactinomycin in Hormone
Figure 13. Global Dactinomycin Market: Hormone (2020-2025) & ($ millions)
Figure 14. Dactinomycin in Plant Medicine
Figure 15. Global Dactinomycin Market: Plant Medicine (2020-2025) & ($ millions)
Figure 16. Global Dactinomycin Market Size Market Share by Application in 2024
Figure 17. Global Dactinomycin Revenue Market Share by Player in 2024
Figure 18. Global Dactinomycin Market Size Market Share by Region (2020-2025)
Figure 19. Americas Dactinomycin Market Size 2020-2025 ($ millions)
Figure 20. APAC Dactinomycin Market Size 2020-2025 ($ millions)
Figure 21. Europe Dactinomycin Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Dactinomycin Market Size 2020-2025 ($ millions)
Figure 23. Americas Dactinomycin Value Market Share by Country in 2024
Figure 24. United States Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Dactinomycin Market Size Market Share by Region in 2024
Figure 29. APAC Dactinomycin Market Size Market Share by Type (2020-2025)
Figure 30. APAC Dactinomycin Market Size Market Share by Application (2020-2025)
Figure 31. China Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 35. India Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Dactinomycin Market Size Market Share by Country in 2024
Figure 38. Europe Dactinomycin Market Size Market Share by Type (2020-2025)
Figure 39. Europe Dactinomycin Market Size Market Share by Application (2020-2025)
Figure 40. Germany Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 41. France Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Dactinomycin Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Dactinomycin Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Dactinomycin Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Dactinomycin Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Dactinomycin Market Size 2026-2031 ($ millions)
Figure 54. APAC Dactinomycin Market Size 2026-2031 ($ millions)
Figure 55. Europe Dactinomycin Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Dactinomycin Market Size 2026-2031 ($ millions)
Figure 57. United States Dactinomycin Market Size 2026-2031 ($ millions)
Figure 58. Canada Dactinomycin Market Size 2026-2031 ($ millions)
Figure 59. Mexico Dactinomycin Market Size 2026-2031 ($ millions)
Figure 60. Brazil Dactinomycin Market Size 2026-2031 ($ millions)
Figure 61. China Dactinomycin Market Size 2026-2031 ($ millions)
Figure 62. Japan Dactinomycin Market Size 2026-2031 ($ millions)
Figure 63. Korea Dactinomycin Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Dactinomycin Market Size 2026-2031 ($ millions)
Figure 65. India Dactinomycin Market Size 2026-2031 ($ millions)
Figure 66. Australia Dactinomycin Market Size 2026-2031 ($ millions)
Figure 67. Germany Dactinomycin Market Size 2026-2031 ($ millions)
Figure 68. France Dactinomycin Market Size 2026-2031 ($ millions)
Figure 69. UK Dactinomycin Market Size 2026-2031 ($ millions)
Figure 70. Italy Dactinomycin Market Size 2026-2031 ($ millions)
Figure 71. Russia Dactinomycin Market Size 2026-2031 ($ millions)
Figure 72. Egypt Dactinomycin Market Size 2026-2031 ($ millions)
Figure 73. South Africa Dactinomycin Market Size 2026-2031 ($ millions)
Figure 74. Israel Dactinomycin Market Size 2026-2031 ($ millions)
Figure 75. Turkey Dactinomycin Market Size 2026-2031 ($ millions)
Figure 76. Global Dactinomycin Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Dactinomycin Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Dactinomycin Market Size 2026-2031 ($ millions)